Related by context. All words. (Click for frequent words.) 74 Vaccine Adverse Events 71 Adverse Event Reporting 70 Vaccine Adverse Event 64 Adverse Event 64 Serious Adverse Events 64 induced hepatotoxicity 62 Medwatch 62 VAERS 62 neuropsychiatric events 62 Hepatotoxicity 61 Postmarketing 60 Package Insert 60 immunomodulatory agents 60 rFVIIa 59 postmarketing surveillance 59 aripiprazole Abilify 59 paroxetine Seroxat 59 thrombotic thrombocytopenic purpura TTP 59 Regranex 59 clevidipine 59 efalizumab 59 cerivastatin 59 Arranon 59 acute phosphate nephropathy 59 Tardive dyskinesia 59 Adverse Events Reporting 59 uridine triacetate 59 OSCS 58 postmarketing adverse 58 MYCAMINE 58 Myfortic 58 hypersensitivity allergic reactions 58 ODOT Fatality Analysis 58 renoprotective 58 FDA MedWatch Adverse Event 58 flecainide 58 gadobutrol 58 FDA MedWatch 58 fluvastatin 58 Avandia Actos 58 Teriparatide 58 Biologics Compendium 58 serotonergic agents 58 Teriflunomide 58 Defense Enrollment Eligibility 58 antiepileptics 58 haloperidol Haldol 58 Sanofi Acomplia 58 Multaq dronedarone 58 nitrofurantoin 58 AVANDIA 58 Torsades de Pointes 58 myopathy rhabdomyolysis 58 TOPAMAX ® 58 Ramelteon 57 neuropsychiatric symptoms 57 Fabry Disease 57 PRIALT 57 Nesiritide 57 Afatinib 57 gabapentin Neurontin 57 FASLODEX 57 Azathioprine 57 events ADEs 57 G6PD deficiency 57 Telithromycin 57 postmarket surveillance 57 abacavir Ziagen 57 SPIRIVA HandiHaler 57 QTc prolongation 57 Pentacel vaccine 57 brivaracetam 57 prucalopride 57 FDA Medwatch 57 REMINYL ® 57 astemizole 57 See CLINICAL PHARMACOLOGY 57 severe hypersensitivity reactions 57 Antiepileptic Drug 57 penicillin allergy 57 lumiracoxib 57 KRAS status 57 Fondaparinux 57 BANZEL 57 concomitant medications 57 dual endothelin receptor antagonist 56 intranasal corticosteroid 56 amifostine 56 Patient Registry 56 FDA CDER 56 sibutramine Meridia 56 hepatic toxicity 56 leflunomide 56 Tigecycline 56 diabetic polyneuropathy 56 AZILECT R 56 ADAGIO study 56 infliximab Remicade 56 Prexige lumiracoxib 56 GnRH agonists 56 Montelukast 56 Tekturna ® 56 postmarketing 56 Contraindications 56 Propoxyphene 56 quinolone antibiotics 56 Boxed Warning 56 Parnate 56 Dacogen decitabine 56 PROactive study 56 F.D.A. 56 pentoxifylline 56 randomized controlled trials RCTs 56 acetaminophen toxicity 56 PRADAXA 56 Zometa zoledronic acid 56 postapproval 56 Full Prescribing Information 56 aldosterone antagonist 56 Registry NOPR 56 Carotid Revascularization Endarterectomy vs. 56 Xelox 56 Zoloft sertraline 56 pioglitazone hydrochloride 56 PML progressive multifocal 56 Singulair montelukast 56 monoamine oxidase inhibitors 56 Motavizumab 56 Combating Counterfeit Drugs 56 Bicillin CR 56 Celebrex celecoxib 56 Pafuramidine 55 ARCOXIA 55 Kugel Mesh 55 mitochondrial toxicity 55 Pharmaprojects 55 Vimpat R 55 ORENCIA ® 55 Paxil paroxetine 55 AVERROES 55 MAGE A3 ASCI 55 placebo controlled studies 55 antibiotic minocycline 55 Humate P 55 hematologic parameters 55 antifibrinolytic 55 edetate disodium 55 Adverse Drug 55 hepatic failure 55 Diabetic Neuropathy 55 Fingolimod 55 Aprotinin 55 Quadramet 55 MEDMARX 55 SmPC 55 piroxicam 55 rasagiline Azilect 55 Warfarin Coumadin 55 tegaserod 55 GW# [003] 55 prospective multicentre 55 Sibutramine Cardiovascular Outcomes 55 ziconotide 55 epoetin alpha 55 teratogenicity 55 Mycophenolate Mofetil 55 Dual Antiplatelet Therapy 55 Anticoagulant 55 DNAwithPap TM Test 55 oral bisphosphonate 55 clomipramine 55 Raptiva R 55 darbepoetin alfa Aranesp 55 overactive bladder symptoms 55 Product Characteristics 55 number NCT# ClinicalTrials.gov 55 CorVue 55 rotigotine transdermal patch 55 nimodipine 55 Zenvia Phase III 55 angioedema 55 statins cholesterol lowering 55 etanercept Enbrel 55 antiplatelet medications 55 Atomoxetine 55 NOMID 55 Erythropoiesis Stimulating Agents ESAs 55 fibromyalgia syndrome 55 MEVACOR 55 Dalbavancin 55 Bucindolol 55 tendon ruptures 55 BEXXAR Therapeutic Regimen 55 Neupro R 55 Clinical Trial Data 55 Patient Outcomes 55 Heavy menstrual bleeding 55 atypical femur fractures 55 Hypotension 55 Clinical Guideline 55 UCB Cimzia 55 Dr. Kate Gelperin 55 Noxafil 55 Accolate 55 NeutroSpec 55 Alteplase 55 FDA Approvable Letter 55 Adverse Events 55 benzonatate 55 Avandia rosiglitazone 54 INFERGEN 54 rosuvastatin Crestor 54 ACTOplus met XR 54 orlistat Xenical 54 MERLIN TIMI 54 paroxetine Paxil 54 MYLOTARG 54 Complete Response 54 Kynapid 54 Suicidality 54 Zocor simvastatin 54 Demonstrates Efficacy 54 inhibitor rofecoxib 54 Phase III Clinical Trials 54 Digitek digoxin 54 Kuvan sapropterin dihydrochloride 54 anticholinergic agents 54 Zarnestra 54 adalimumab Humira 54 oral sodium phosphate 54 placebo controlled clinical trials 54 Romiplostim 54 TNF blocker 54 Clinical Practice Guideline 54 Schizophrenia Treatment 54 OHRP 54 bovine thrombin 54 Vidaza azacitidine 54 alfuzosin 54 pyridostigmine 54 aseptic meningitis 54 BARI 2D 54 Doribax 54 Digoxin 54 Tussionex 54 VADT 54 tardive dyskinesia TD 54 heparin induced thrombocytopenia 54 TORISEL TM 54 Optimark 54 Hyperkalemia 54 Darvocet Darvon 54 hemorrhagic cystitis 54 SANVAR 54 AZILECT ® 54 Abatacept 54 reflux disease GERD 54 MedWatch 54 Moxifloxacin 54 STELARA ™ 54 riociguat 54 Akathisia 54 Drug Utilization 54 CAMMS# 54 Hydroxyurea 54 renal toxicity 54 fosbretabulin 54 Asclera 54 SAEs 54 Rofecoxib 54 cromolyn sodium 54 Medidur TM FA 54 ezetimibe simvastatin 54 eosinophilic pneumonia 54 Muraglitazar 54 aldosterone antagonists 54 STRIDE PD 54 Velcade bortezomib 54 varicella infection 54 Mitigation Strategies REMS 54 Ziprasidone 54 interstitial pneumonia 54 Prilosec omeprazole 54 Zelapar 54 anticonvulsant medications 54 Hypercholesterolemia 54 TMP SMX 54 guanfacine extended release 54 tricyclic antidepressant 54 hepatorenal syndrome 54 topiramate Topamax 54 sitaxsentan 54 hormone therapy HT 54 telithromycin 54 vaccine RotaTeq 54 Sprycel dasatinib 54 oral bisphosphonates 54 EMBEDA ™ 54 mycophenolate mofetil 54 Tasigna nilotinib 54 Candesartan 54 CONTRAINDICATIONS 54 prasugrel Effient 54 Arterial Hypertension 54 Tygacil 54 sleep disorder narcolepsy 54 Alequel 54 Aliskiren 54 Omalizumab 54 brompheniramine 54 RhuDex 54 Cellcept 54 HMG CoA reductase inhibitors 54 Adverse reactions 54 proton pump inhibitors PPIs 54 ARICEPT R 54 eculizumab therapy 54 risperidone Risperdal 54 Adverse Reactions 54 venlafaxine Effexor 54 Immunologic 53 SUBOXONE 53 Ropinirole 53 antiarrhythmic drug 53 QT interval prolongation 53 ADEs 53 HoFH 53 LEVAQUIN 53 Eculizumab 53 Daptomycin 53 JANUMET 53 ZYVOX 53 neuropsychiatric adverse 53 teratogenic effects 53 Remicade infliximab 53 hepatotoxicity 53 Advagraf 53 ATACAND 53 celecoxib Celebrex 53 vernakalant hydrochloride 53 lenalidomide Revlimid 53 Stenting Trial CREST 53 BYETTA exenatide injection 53 Gaboxadol 53 Roflumilast 53 acitretin 53 valdecoxib 53 phototoxicity 53 Randomized Controlled Trials 53 Investigational Drugs 53 Tumor Response 53 gastro oesophageal reflux disease 53 propafenone 53 mild hepatic impairment 53 allergen immunotherapy 53 balsalazide tablet 53 glitazones 53 prolonged QT interval 53 levocetirizine 53 reboxetine 53 biologic DMARDs 53 Lipid lowering 53 chronic noncancer pain 53 pioglitazone HCl 53 Cheson 53 OsmoPrep 53 CDER FDA 53 OPTIMIZE HF 53 Lotensin 53 Product Monograph 53 AdreView 53 Vaprisol 53 Therapeutics Bulletin DTB 53 leukoencephalopathy 53 Angioedema 53 danazol 53 ISMP 53 invasive aspergillosis 53 epidural steroid injection 53 Hematologic 53 AOD# [002] 53 Etanercept 53 ARIXTRA R 53 voriconazole 53 sorafenib Nexavar 53 Triptan 53 labetalol 53 Coumadin Warfarin 53 Symmetrel 53 torsade de pointes 53 sucralfate 53 Effexor venlafaxine 53 Microalbuminuria 53 SPARLON 53 nelfinavir Viracept 53 antidiabetic drugs 53 pharmacokinetic interaction 53 Anticonvulsants 53 levetiracetam Keppra 53 terlipressin 53 vardenafil Levitra 53 thiazide 53 Lumiracoxib 53 Rosiglitazone 53 Spiriva HandiHaler 53 Sanctura XR 53 selegiline 53 Celecoxib APC trial 53 morphine sulphate 53 Severe Sepsis 53 quetiapine Seroquel 53 mesylate 53 NSAID diclofenac 53 Glycopyrrolate 53 Intervention Trial GAIT 53 Aptivus 53 cardioembolic stroke 53 RISPERDAL ® 53 Medication Errors 53 enoxaparin Lovenox 53 ticagrelor Brilinta 53 Metabolic Disorder 53 FDA 53 Dasatinib 53 pioglitazone Actos 53 ACIPHEX 53 IFN β 53 Antihistamine 53 Wellstat 53 icatibant 53 KAPIDEX 53 Valtrex valacyclovir 53 glucocorticoid induced osteoporosis 53 Safe Medication Practices ISMP 53 β blockers 53 Clinicaltrials.gov 53 heterozygous FH 53 neuroleptic 53 Sildenafil Viagra 53 Captopril 53 Approvable 53 SIMCOR 53 Safinamide 53 TNF therapy 53 INVEGA ® 53 Catapres 53 Cimzia TM 53 Cimetidine 53 NSQIP 53 Genzyme Myozyme 53 methemoglobinemia 53 canakinumab 53 adrenal suppression 52 Tofranil 52 cytomegalovirus infection 52 ipratropium bromide 52 Acute Decompensated Heart Failure 52 Septic Shock 52 Med eXpert 52 sertraline Zoloft 52 Telzir 52 Ranolazine 52 Progressive Multifocal Leukoencephalopathy 52 cardiac conduction 52 Topamax topiramate 52 DASISION 52 Prescriber 52 bolus dose 52 Cancidas 52 pravastatin Pravachol 52 Adenoma Prevention 52 Aveed 52 nonsteroidal 52 Rasilez Tekturna 52 LYSTEDA 52 olanzapine LAI 52 NACI 52 HeFH 52 cediranib 52 PROCRIT R 52 denileukin diftitox 52 VAPRISOL 52 NATRECOR ® 52 necrotizing pancreatitis 52 cefepime 52 fluoxetine Prozac 52 Darvon Darvocet 52 vasogenic edema 52 Eraxis 52 pathophysiologic mechanism 52 aclidinium 52 venous thromboembolic disease 52 nimesulide 52 salmeterol Serevent 52 liposomal amphotericin B 52 glyceryl trinitrate 52 abacavir containing 52 hypertrophic obstructive cardiomyopathy 52 TOPROL XL 52 Roche Xeloda 52 Treatment Outcome 52 Pharmacokinetic 52 selective modulator 52 Lantus insulin 52 optic neuropathy NAION 52 GSK Avandia 52 Sporanox 52 Glatiramer Acetate 52 LibiGel ® 52 Onrigin 52 Advaxis Incorporated OTCBB ADXS 52 ENTEREG ® 52 Multidrug 52 bullous 52 1mg 2mg 52 ximelagatran 52 Focalin XR 52 Natalizumab 52 phase IIIb 52 urticaria hives 52 Desvenlafaxine 52 NCCN guidelines 52 etomidate 52 Sycrest 52 Perforomist ™ Inhalation Solution 52 Antihypertensive 52 Overactive Bladder 52 opiods 52 conjugated estrogen 52 aneurysmal subarachnoid hemorrhage 52 L lysine 52 Rasilamlo 52 Serious adverse reactions 52 Insulin detemir 52 Liprotamase 52 atorvastatin Lipitor 52 leukotriene receptor antagonists 52 Nocturia 52 ADVANCE PD 52 Intelence 52 Levothyroxine 52 desvenlafaxine 52 intensive statin therapy 52 severe hypercholesterolemia 52 buccal tablets 52 Carvedilol 52 Eszopiclone 52 Prostate AdenoCarcinoma Treatment 52 statin medications 52 CIMZIA TM certolizumab pegol 52 bone scintigraphy 52 gastrointestinal perforation 52 Pharmacoeconomic 52 ruboxistaurin 52 neuroleptic malignant syndrome 52 non selective NSAIDs 52 Tekturna HCT 52 NHTSA Fatality Analysis 52 allergic dermatitis 52 KETEK 52 Adjunctive 52 intravenous bisphosphonates 52 ACCF AHA 52 endocrinologic 52 FDA CFSAN 52 PDUFA Date 52 troglitazone 52 Frovatriptan 52 Sanvar R 52 Exelon rivastigmine 52 Raptiva ® 52 rosiglitazone maleate 52 zolpidem Ambien 52 Venous Thromboembolism 52 cancerous colon polyps 52 Efficacy Study 52 Vimpat lacosamide 52 pamidronate 52 Epirubicin 52 containing diphenhydramine brompheniramine 52 Anzemet 52 Torisel 52 Kepivance 52 anti IgE antibody 52 antiplatelet therapies 52 TOPAMAX R 52 newer atypical antipsychotics 52 RE LY 52 H2 receptor antagonists 52 Interferon Beta 52 cardiac repolarization 52 topical diclofenac 52 selective NSAIDs 52 erythropoietin stimulating agents 52 Pivotal Phase III 52 Severe Asthma 52 posaconazole 52 milrinone 52 Amgen Nplate 52 MADIT II 52 Arixtra ® 52 Val HeFT 52 Diagnostic Criteria 52 omeprazole Prilosec 52 ONTARGET 52 divalproex sodium 52 Sade Oguntola 52 SUTENT ® 52 Glatiramer acetate 52 Fluconazole 52 Buspirone 52 GEMZAR 52 Anticholinergic 52 ECASS 52 clinically meaningful differences 51 antiemetics 51 Intravenous Formulation 51 ® pioglitazone HCl 51 pharmacokinetic PK study 51 Renal dysfunction 51 hydroxychloroquine 51 Anticoagulation 51 oral hypoglycemic 51 pregabalin Lyrica 51 pharmacokinetic interactions 51 Meridia sibutramine 51 Xyrem ® 51 AZILECT 51 EMBEDA TM 51 Bifeprunox 51 ZOMIG 51 EDARBI 51 PPSV# 51 Latuda 51 opioid overdose 51 Topiramate 51 Dexilant 51 NOXAFIL 51 Generalized Anxiety Disorder 51 Reminyl galantamine 51 alvimopan 51 LAB CGRP 51 gemfibrozil 51 invasive candidiasis 51 Cardiac Outcomes 51 Epidemiological Studies Unit 51 Unstable Angina 51 CYP#D# inhibitor 51 transaminase elevations 51 Topical Gel 51 Accelerated Approval 51 Mirapexin 51 Interferon Alfa 51 Egrifta 51 Bextra valdecoxib 51 tetracycline antibiotic 51 clobazam 51 Zaleplon 51 nonhematologic adverse reactions 51 QVAR ® 51 Levetiracetam 51 Pemetrexed 51 QT prolongation 51 Perforomist Inhalation Solution 51 Savella TM 51 ENDEAVOR III 51 Erythropoietic 51 immunosuppressant drug 51 pancytopenia 51 Eli Lilly Cymbalta 51 Telavancin 51 ischemic colitis 51 EFFEXOR XR 51 acamprosate calcium 51 Removab 51 pimozide 51 venous thromboembolisms 51 Diamyd r 51 GRALISE 51 Tolamba 51 Betaferon R 51 antiplatelet drugs 51 zafirlukast 51 containing drospirenone 51 Detox Diets Doreen Gentzler 51 Anti depressant 51 Cardiotoxicity 51 palivizumab 51 COX 2s 51 Azacitidine 51 Nebulized 51 thrombotic events 51 Devices Advisory Panel 51 malignant ascites 51 Glybera R 51 Treatment Resistant 51 antidiabetic drug 51 parasitemia 51 briakinumab 51 Viracept nelfinavir 51 Mutation Analysis 51 Raptiva efalizumab 51 Phase IIb III 51 Cerezyme Fabrazyme Myozyme Aldurazyme 51 patientswith 51 macrolide antibiotic 51 Complete Prescribing Information 51 ReoPro 51 Tysabri natalizumab 51 methodological limitations 51 paroxetine sertraline 51 lucinactant 51 Drug Absorption 51 Aflibercept 51 INVEGA ® SUSTENNA ® 51 heFH 51 Gamunex C 51 PROVIGIL 51 terazosin 51 Baxter Heparin 51 COPD exacerbations 51 dual antiplatelet 51 mesilate 51 incidentalomas 51 Centocor Remicade 51 Selective Serotonin Reuptake Inhibitor 51 acid suppressive therapy 51 paracetamol acetaminophen 51 Clinical Practice Guidelines 51 anticoagulant warfarin 51 conjugated estrogens 51 ImmuKnow assay 51 cinacalcet 51 induced akathisia 51 Zavesca R 51 clopidogrel bisulfate 51 ACTOS ® 51 tiotropium Spiriva 51 varenicline Chantix 51 mycophenolate 51 antiepileptic drugs 51 zolmitriptan 51 RE LY trial 51 Xinlay 51 immunomodulatory therapies 51 syncope fainting 51 griseofulvin 51 Wellbutrin bupropion 51 PFGE 51 rivaroxaban Xarelto 51 liver toxicity 51 adverse reactions 51 Valproate 51 isoproterenol 51 chromium supplementation 51 Phase 2b Study 51 TAXOTERE ® 51 Plavix clopidogrel bisulfate 51 Patients Receiving 51 INTELENCE 51 muraglitazar 51 candidemia 51 Corlux 51 Pulminiq 51 Valsartan 51 PYY #-# 51 tibolone 51 EMEND 51 ergotamine 51 Daytrana ® 51 Rimantadine 51 APPRAISE 51 Morbidity Weekly 51 Foradil Aerolizer 51 motavizumab 51 Blood Glucose Monitor 51 Loxapine 51 Zyflo CR 51 Lung Injury 51 Bupropion 51 COREG 51 Physician Quality 51 discontinued Viread 51 VTE prophylaxis 51 Teysuno 51 coumadin 51 PREZISTA r 51 Benzodiazepine 51 RevAssist R 51 vWD 51 intranasal corticosteroids 51 blood thinner Warfarin 51 aromatase inhibitors AIs 51 Miacalcin 51 hyperacute 51 oxypurinol 51 XIAFLEX ™ 51 treatment emergent AEs 51 Prospective Randomized 51 eMDR 51 BenzaClin R 51 Ketek 51 sedative hypnotics 51 beta interferons 51 Erythropoiesis stimulating agents 51 Supplemental Biologics License Application 51 hyperprolactinemia 51 dexmedetomidine 51 ENDEAVOR IV 51 biologic DMARD 51 Coronary Artery Bypass Graft 51 Zyprexa Risperdal 51 VFEND 51 Patency 51 Inegy 51 Dacogen injection 51 antiarrhythmic drugs 51 Post Herpetic Neuralgia 51 PROCRIT 51 Actos pioglitazone 51 metformin HCl 51 Cintredekin besudotox 51 imipramine Tofranil 51 Data Extraction 51 randomized multicenter Phase III 51 rimonabant Acomplia 51 Cervical Dystonia 51 Soriatane 51 Peer Reviewed Medical 51 AGHD 51 treat enlarged prostate 51 Dostinex 51 Luveris 51 Community Acquired Pneumonia 51 ALGRX 51 Prescribers 51 antiepileptic drugs AEDs 51 VIIBRYD 51 Mycamine 51 insulin glulisine 51 ROTARIX 51 fatal anaphylactic 51 Prescribing Information 51 Capoten 51 Temsirolimus 51 ARIXTRA 51 Inflammatory Markers 51 RISPERDAL 51 AstraZeneca Iressa 51 Tadalafil Cialis 51 RAPTIVA 51 valvular heart disease 51 dysrhythmias 51 MenACWY CRM 51 l arginine 51 acarbose 51 JAAPA 51 intravitreal implant 51 Didanosine 51 radioimmunotherapy RIT 51 Shows Efficacy 51 ARCALYST ® 51 Innohep 51 zoledronate 51 inflammatory biomarkers 51 headache abdominal pain 51 journal CHEST 51 Pulmonary Arterial Hypertension 51 Expanded Indication 51 Dapoxetine 51 aclidinium bromide 51 PRISTIQ 51 FENTORA 51 midodrine 51 teratogenic 51 Extended Release 51 Lovastatin 51 Pyridorin 51 Phenylephrine 51 Mg Usa 51 Sudden Unexplained Infant Death 51 antiresorptive 51 Cefixime 51 Oxymorphone ER 51 OvaDx 50 HIV HCV coinfected 50 Exforge HCT 50 digoxin toxicity 50 Intravitreal 50 verteporfin 50 Echocardiographic 50 immune suppressing medications 50 NATRECOR R 50 TLK# 50 Dupuytren Contracture 50 Potiga 50 Apixaban 50 anakinra 50 clazosentan 50 Pegloticase 50 Febuxostat 50 Pharmacodynamics 50 CANCIDAS 50 eprotirome 50 anaphylactoid reactions 50 AneuRx 50 Coronary Revascularization 50 Cimzia certolizumab pegol 50 injectable formulations 50 Medication Adherence 50 hypersensitivity reaction 50 NSF NFD 50 Epidermal Growth Factor Receptor 50 HFA MDI 50 nonrandomized studies 50 ropinirole 50 Cytochrome P# 50 HCUP 50 MULTAQ 50 EGFRIs 50 Phase IIIb 50 Iressa gefitinib 50 Johann Liang 50 bisoprolol 50 pemetrexed Alimta 50 BRILINTA 50 pulmonary toxicity 50 Renal Function 50 RREs 50 FDA Advisory Panel 50 varenicline tartrate 50 Serebruany 50 Initiate Clinical Trial 50 Musculo Skeletal Disorders 50 lansoprazole Prevacid 50 oral antidiabetes drugs 50 Duragesic patches 50 postexposure prophylaxis 50 Femara letrozole 50 symptomatic intracranial 50 aromatase inhibitor therapy 50 Eltrombopag 50 Climara Pro 50 elevated ALT 50 Antiplatelet 50 bone marrow suppression 50 agranulocytosis 50 overdosage 50 CELVAPAN H#N# 50 Lipid Lowering Treatment 50 Syndromic Surveillance 50 serotonin norepinephrine reuptake inhibitor 50 Kiacta 50 nonstimulant 50 NSAID ibuprofen 50 antihistamine medicines 50 Afinitor everolimus 50 Exertional 50 Diabetologia 50 Vigabatrin 50 Plaquenil 50 Acute Ischemic Stroke 50 EXALGO 50 glatiramer 50 ZOSTAVAX 50 entitled Formulary Advantages 50 PA PSRS 50 LAF# 50 antiangiogenic therapy 50 Venlafaxine 50 Tasigna prolongs 50 mycophenolic acid 50 Insulin Delivery Systems 50 Pramipexole 50 phenytoin 50 Effient prasugrel 50 headache nasopharyngitis 50 Nexavar sorafenib 50 Qualaquin 50 VerifyNow 50 Abacavir 50 COX inhibitors 50 ZACTIMA 50 Bioequivalence 50 Acthar Gel 50 Exploratory IND 50 potentially hepatotoxic 50 NCCN Drugs 50 Thrombotic 50 vaccinees 50 JAK Inhibitor 50 Geodon ziprasidone 50 Sevelamer 50 NIH Consensus 50 SMZ TMP 50 Resolute stent 50 Sipuleucel T 50 Peripheral edema 50 Antiplatelet Therapy